Table 3—

Inflammatory biomarkers in type 1 diabetes and control subjects

MeasurementsType 1 diabetic subjectsControl subjectsP
n3839
U-15-keto-dihydro-PGF2α (pmol/mmol creatinine)310 ± 100260 ± 100P < 0.01
P-15-keto-dihydro-PGF2α (pg/ml)20.1 ± 12.318.6 ± 9.9NS
IL-6 (mg/l)1.41 ± 0.641.19 ± 0.790.037
CRP (mg/l)1.0 ± 1.161.15 ± 1.34NS
SAA (mg/l)3.02 ± 2.753.58 ± 2.71NS
  • Data are means ± SD. P, plasma; U, urinary.